Serengen and Deargen are excited to announce their collaboration to accelerate the drug discovery process. This strategic partnership brings together Serengen’s novel DNA encoded library (DEL) technology with Deargen’s leading AI-driven drug discovery…
The “Esophagoscopes Market Size by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures and Forecast to 2033” database has been added to ResearchAndMarkets.com’s offering. This report was built to visualize quantitative…
Octave® Bioscience, Inc. was honored in Fast Company’s Innovation by Design Awards for 2023 in the Health category. The Innovation by Design Awards, which can be found in the September 2023 issue of Fast…
The global vital signs monitoring devices market is expected to reach a value of $33.36 billion by 2028 from $20.6 billion in 2022, growing at a CAGR of 8.36% from…
The “MedReg 2023 – Annual Medical Device Regulatory Confex” training has been added to ResearchAndMarkets.com’s offering. Step into the realm of regulatory excellence at MedReg 2023, the Annual Medical Devices Regulatory Confex that will…
AGIC Capital (“AGIC”), a growth-oriented European-Asian private equity firm with $2.2 billion of assets under management has completed the investment of an undisclosed amount into AP Technologies (“AP Tech”), an…
DermaSensor Inc., a health technology company equipping primary care physicians (PCPs) with a non-invasive device for evaluating suspicious skin lesions, presented today promising results from a sub-analysis of the DERM-SUCCESS…
Henry Schein, Inc. (Nasdaq: HSIC) reminds its customers in Hawaii that the Henry Schein Customer Assistance Hotline is open for dentists and physicians who may experience operational, logistical, or financial…
McKesson Medical-Surgical, an affiliate of the McKesson Corporation, will participate as a silver sponsor of the National Association of Community Health Centers National Health Center Week 2023 (NHCW) Aug. 6-12.…
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today reported financial results and business highlights for the…
Owens & Minor, Inc. (NYSE: OMI)today reported financial results for the second quarter ended June 30, 2023. Second Quarter Key Highlights: “The second quarter of 2023 shows a continuation of…
MicroVention, Inc., a global neurovascular company and wholly owned subsidiary of Terumo Corporation, is celebrating the one-year anniversary of the company’s FRED™ X Flow Diverter. In close collaboration with physician…